SI120080: Linagliptin-d4 Pack Size:5 mg 5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl- 3(2H)-pyridazinone-d3

5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl- 3(2H)-pyridazinone-d3

6-di-O-acetyl-α-D-]-L-threonine

or for conjugation and analytical work rather than direct Fmoc-SPPS

89 / HHV1-gB(UniProt ID P08665) synthetic glycopeptide HSV1-gB fragment (Thr53-Pro56

96 / Synthetic glycopeptide fragment (Thr1179-Asp1194

SI120080: Linagliptin-d4 Pack Size:5 mg 5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl- 3(2H)-pyridazinone-d3C25H24D4N8O2 476. 54 Diabetes Type 2 Linagliptin d4 8 [(3R) 3 Amino 1 piperidinyl] 7 (2 butynyl) 3,7 dihydro 3 methyl 1 [(4 methyl 2 quinazolinyl)methyl] 1H purine 2,6 dione d4; BI 1356 d4; BI 1356BS d4; ONDERO d4